AEON
AEON Biopharma, Inc. Class A Common Stock (AEON)
$11
About AEON Biopharma, Inc. Class A Common Stock (AEON)
AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Details
Daily high
$1.22
Daily low
$1.05
Price at open
$1.22
52 Week High
$1.45
52 Week Low
$0.38
Market cap
28.1M
Dividend yield
0.00%
Volume
69,625
Avg. volume
84,491
P/E ratio
.22
AEON Biopharma, Inc. Class A Common Stock News
Details
Daily high
$1.22
Daily low
$1.05
Price at open
$1.22
52 Week High
$1.45
52 Week Low
$0.38
Market cap
28.1M
Dividend yield
0.00%
Volume
69,625
Avg. volume
84,491
P/E ratio
.22